methylphenidate has been researched along with Obesity, Morbid in 2 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
Obesity, Morbid: The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this article, we report and analyze a case of 52-year-old male patient with morbid obesity and attention-deficit/hyperactivity disorder (ADHD) who experienced lack of methylphenidate efficacy after Roux en-Y gastric bypass (RYGB), which was eventually resolved by using the transdermal patch instead of an oral product." | 4.95 | Impaired oral absorption of methylphenidate after Roux-en-Y gastric bypass. ( Azran, C; Dahan, A; Langguth, P, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azran, C | 1 |
| Langguth, P | 1 |
| Dahan, A | 1 |
| Ludvigsson, M | 1 |
| Haenni, A | 1 |
1 review available for methylphenidate and Obesity, Morbid
| Article | Year |
|---|---|
Impaired oral absorption of methylphenidate after Roux-en-Y gastric bypass.
Topics: Administration, Oral; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulan | 2017 |
1 other study available for methylphenidate and Obesity, Morbid
| Article | Year |
|---|---|
Methylphenidate toxicity after Roux-en-Y gastric bypass.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Diabetes Me | 2016 |